Watch Ticker

Tempest Therapeutics, Inc. Common Stock

Go to Tempest Therapeutics, Inc. Common Stock Website

$3.18

(%)

Live

Previous Close

$3.18

Day Range

$ - $

Previous Day Range

$ - $

Market Cap

$70.7 million USD

Day Vol.

Previous Day Vol.

Currency

USD

Primary Exchange

Nasdaq

Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic pr...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Tempest Therapeutics - Tempest Reports First Quarter 2024 Financial Results and Provides Business Update

BRISBANE, Calif., May 09, 2024 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-classi targeted and immune-mediated therapeutics to fight cancer, today reported financial results for the quarter ended March 31, 2024, and provided a corporate update.

Related tickers: TPST.

Read Full Article

Tempest Therapeutics - Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

BRISBANE, Calif., April 26, 2024 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-class1 targeted and immune-mediated therapeutics to fight cancer, today announced that the Compensation Committee of the Company’s Board of Directors granted one employee nonqualified stock options to purchase an aggregate of 5,400 shares of its common stock under the Company’s 2023 Inducement Plan.

Related tickers: TPST.

Read Full Article

Trending Tickers

FLGC

XNAS

$1.31

(%)

IBIT

XNAS

$38.28

(%)

LASE

XNAS

$2.16

(%)

MGAM

XNAS

$0.02

(%)

MLGO

XNAS

$0.00

(%)